The short answer
Calcium advice depends on the raltegravir regimen and the calcium product. Calcium carbonate antacid needs no separation with Isentress 400 mg twice daily, but is not recommended with Isentress HD 1,200 mg once daily. A blanket six-hour gap is therefore not the right instruction for every calcium product.
What this answer covers
Adult oral raltegravir tablets and calcium products. Direct studies used calcium carbonate antacid; nutritional calcium salts and mixtures require a separate assessment. Isentress 400 mg twice daily and Isentress HD 1,200 mg once daily remain distinct.
- Supplement or preparation
- Calcium
- Medication ingredient
- raltegravir
Why are there two different answers?
Isentress 400 mg is usually taken twice daily, while Isentress HD uses two 600 mg tablets once daily in eligible patients. The formulations and exposure patterns differ. Current U.S. guidance allows calcium carbonate antacid with the 400 mg twice-daily regimen without dose adjustment or separation, but discourages the same antacid with the 1,200 mg once-daily regimen. The word raltegravir alone does not identify the correct instruction.
What happened in the once-daily study?
Calcium carbonate taken with 1,200 mg raltegravir reduced overall exposure substantially. Giving the calcium twelve hours later largely preserved total exposure, but the 24-hour raltegravir concentration was still lower. That distinction matters for a medicine intended to maintain activity throughout the dosing interval. A six-hour gap is not an established way to make this once-daily antacid combination acceptable.
What about calcium taken for nutrition?
A calcium supplement is not automatically equivalent to the antacid dose used in a study. NIH guidance for polyvalent mineral supplements advises raltegravir at least two hours before or six hours after when coadministration is necessary, with virologic monitoring. UK specialist guidance for 400 mg raltegravir uses a different supplement schedule. Have your HIV pharmacist reconcile the exact product and regimen instead of applying one interval to all calcium use.
What information should I bring?
Bring the raltegravir bottle, calcium label, elemental calcium amount and usual meal and medication times. Include multivitamins and heartburn remedies, since each may add calcium or other minerals. Do not switch between Isentress formulations or alter the HIV dose yourself. A pharmacist can confirm whether the product falls under the specific calcium carbonate antacid instruction or needs a separate supplement plan.
Evidence and practical considerations
Absorption & effectiveness
Calcium advice depends on the raltegravir regimen and the calcium product. Calcium carbonate antacid needs no separation with Isentress 400 mg twice daily, but is not recommended with Isentress HD 1,200 mg once daily. A blanket six-hour gap is therefore not the right instruction for every calcium product.
- Exact scope
- Adult oral raltegravir tablets and calcium products. Direct studies used calcium carbonate antacid; nutritional calcium salts and mixtures require a separate assessment. Isentress 400 mg twice daily and Isentress HD 1,200 mg once daily remain distinct. with Adult oral raltegravir tablets: Isentress 400 mg twice daily versus Isentress HD 1,200 mg once daily
- Medication form and route
- Adult oral raltegravir tablets: Isentress 400 mg twice daily versus Isentress HD 1,200 mg once daily; oral mineral, supplement or antacid within stated preparation scope
- Timing or duration
- Short antacid pharmacokinetic studies; nutritional supplement timing advice is guideline-based rather than a trial establishing a universal six-hour interval.
What remains uncertain
- Antacid amount and formulation matter. The no-separation instruction applies to calcium carbonate antacid with 400 mg twice daily, not all products or the once-daily formulation. Specialist supplement timing guidance differs by jurisdiction.
Factors that may matter: Exact mineral ingredients, preparation and elemental amount; Isentress 400 mg twice daily versus Isentress HD 1,200 mg once daily; Food and direction of administration when applicable; Concurrent mineral products, adherence and viral-load monitoring.
Read the supporting source summaries
Source 1: current manufacturer U.S. regulatory prescribing information
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People using oral raltegravir; adult 400 mg twice-daily Isentress and 1,200 mg once-daily Isentress HD regimens are distinguished.
Aluminum/magnesium antacids are not recommended even with staggered dosing. Calcium carbonate antacid requires no adjustment with 400 mg twice daily but is not recommended with 1,200 mg once daily. With the once-daily regimen, a 12-hour gap still left markedly reduced trough levels.
How this applies: Explicit salt-to-active-moiety bridge for exact RxNorm raltegravir. Each article preserves the 400 mg twice-daily versus 1,200 mg once-daily distinction and does not extend these tablet data to pediatric chewable tablets or suspension. Exact article scope: Adult oral raltegravir tablets and calcium products. Direct studies used calcium carbonate antacid; nutritional calcium salts and mixtures require a separate assessment. Isentress 400 mg twice daily and Isentress HD 1,200 mg once daily remain distinct.
The adult tablet regimens are not interchangeable. These exact antacid studies do not establish effects of all dietary mineral salts, zinc, iron or vitamin-only products. Healthy and HIV-positive study conditions differ; reductions in drug concentrations do not directly quantify treatment failures.
Source 2: U.S. expert clinical treatment guideline
clinicalinfo.hiv.gov · Source check Sep 10, 2026
Population: Adults and adolescents receiving integrase inhibitor regimens for HIV.
Bictegravir mineral directions depend on cation and food. If raltegravir must be used with polyvalent mineral supplements, give it at least 2 hours before or 6 hours after and monitor virologic response. Multivitamin chelation magnitude is uncertain. Raltegravir antacid rules are separate: avoid Al/Mg, and distinguish calcium carbonate 400 mg twice daily from 1,200 mg once daily. Do not coadminister bictegravir with St. John’s wort.
How this applies: Exact-drug management guidance. Bictegravir sodium and raltegravir potassium are interpreted through their labels’ active-moiety equivalents. Calcium/iron food exceptions for bictegravir do not transfer to raltegravir. Exact article scope: Adult oral raltegravir tablets and calcium products. Direct studies used calcium carbonate antacid; nutritional calcium salts and mixtures require a separate assessment. Isentress 400 mg twice daily and Isentress HD 1,200 mg once daily remain distinct.
Expert recommendations include predicted interactions where exact-pair clinical studies are absent. A suggested supplement schedule does not supersede the distinct antacid avoidance instructions. No universal safe dose or virologic risk percentage is established.
Source 3: peer-reviewed prospective human pharmacokinetic study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 20 adults with HIV already receiving raltegravir in a fixed-sequence pharmacokinetic study; 19 evaluable for several comparisons.
Simultaneous calcium carbonate reduced exposure to 28% and 24-hour concentration to 52% of reference. Twelve-hour-separated calcium carbonate preserved overall exposure but reduced 24-hour concentration to 43%; separated Al/Mg reduced that concentration to 42%.
How this applies: Exact raltegravir with specified antacids under adult once-daily conditions. Combined Al/Mg cannot distinguish the individual ion’s contribution. Exact article scope: Adult oral raltegravir tablets and calcium products. Direct studies used calcium carbonate antacid; nutritional calcium salts and mixtures require a separate assessment. Isentress 400 mg twice daily and Isentress HD 1,200 mg once daily remain distinct.
Original abstract was read; full journal text was not retrieved. Drug concentration endpoints, not virologic failure rates. This 1,200 mg once-daily result cannot be directly assigned to the 400 mg twice-daily formulation or to every nutritional mineral product.
Source 4: specialist pharmacy patient guidance
hivpa.org · Source check Sep 10, 2026
Population: People prescribed Isentress 400 mg twice daily; UK pharmacy guidance.
Advises avoiding aluminum/magnesium antacids, four-hour separation either side for calcium/magnesium supplements and multivitamins, and two-hour separation either side for iron/zinc.
How this applies: Documents a genuine guideline difference so an existing two-hour suggestion is not described as wholly invented. The consumer article states its U.S. NIH basis and directs regimen-specific reconciliation with the HIV pharmacist. Exact article scope: Adult oral raltegravir tablets and calcium products. Direct studies used calcium carbonate antacid; nutritional calcium salts and mixtures require a separate assessment. Isentress 400 mg twice daily and Isentress HD 1,200 mg once daily remain distinct.
Patient guidance, not a comparative timing trial. The schedules differ from the U.S. NIH 2-hours-before/6-hours-after supplement recommendation. Its 400 mg scope does not establish instructions for Isentress HD 1,200 mg once daily. The 2026 URL folder is not the clinical review date.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Current exact-drug labeling and guidance checked; original human studies and neutral findings assessed. Current statements adjudicated with formulation, food and directional timing corrections. Article written; clinical sign-off not recorded. | |
| Research summary published |
Article revision: a2090b5612dc3bad
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.